Skip to content

Dexamethasone-Ondansetron Combined with Diphenhydramine for Preventing Postoperative Nausea and Vomiting in Thoracoscopic lung surgery: A double blind randomized controlled trial

Dexamethasone-Ondansetron Combined with Diphenhydramine for Preventing Postoperative Nausea and Vomiting in Thoracoscopic lung surgery: A double blind randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110881
Enrollment
Unknown
Registered
2025-10-22
Start date
2025-10-31
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Nausea and Vomiting

Interventions

experimental group:During anesthesia induction, 10mg dexamethasone was intravenously injected, 8mg ondansetron was intravenously injected 30 minutes before the end of the surgery, and 20mg diphenhydra
control group:During anesthesia induction, 10mg dexamethasone was intravenously injected, and 8mg ondansetron was intravenously injected 30 minutes before the end of the surgery.

Sponsors

Anesthesia and Surgery Center of West China Hospital Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 18-75 years old; 2. ASAI-III level; 3. Selective thoracoscopic lobectomy (including thoracoscopic wedge resection, thoracoscopic segmentectomy, thoracoscopic lobectomy); 4. Voluntary use of intravenous analgesia pump; 5. Apfel risk factors>=3; 6. The subjects have a clear understanding and voluntarily participate in this study, can sign an informed consent form, and voluntarily follow the research process.

Exclusion criteria

Exclusion criteria: 1. There are contraindications for the use of dexamethasone, ondansetron, and diphenhydramine; 2. Preoperative use of antiemetic drugs; 3. Language communication barriers; 4. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
The incidence of PONV within 24 hours after surgery;The severity of nausea, retching, and vomiting within 0-24 and 25-72 hours after surgery;Use of emergency antiemetic drugs within 0-24h and 25-72h after surgery;

Secondary

MeasureTime frame
The incidence of nausea, retching, and vomiting within 0-24 and 25-72 hours after surgery;Pain intensity during rest and coughing at 24h and 72h postoperatively;Postoperative hospitalization duration;Total hospitalization expenses;Incidence of adverse drug reactions;

Countries

China

Contacts

Public ContactLiu Fei

Anesthesia and Surgery Center of West China Hospital Sichuan University

30333870@qq.com+86 189 8060 5856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026